{"entity":{"id":"nct06555133","kind":"trial","name":"Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC","aka":["METEORITE"],"tldr":"A phase 2 trial in colorectal cancer, run by Brown University, now recruiting.","summary":"Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC is a phase 2, interventional study registered as NCT06555133 by Brown University, with a registry enrolment figure of 18 participants, started 2025-04-07 and due to reach its primary completion in 2026-09-01. Interventions recorded: yttrium-90 radioembolization. Conditions listed: Colorectal Carcinoma Metastatic in the Liver. Primary outcome: To assess the preliminary efficacy with the combination of yttrium-90, capecitabine, and atezolizumab based on the intrahepatic disease control rate (iDCR) at 12 weeks. Colorectal eligibility wording from the registry: \"Histologically confirmed diagnosis of colorectal adenocarcinoma\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06555133","url":"https://clinicaltrials.gov/study/NCT06555133"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["sirtex"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06555133","phase":"2","setting":"A Phase II Pilot Study of yttriuM-90 in Combination With capEcitabine and aTezolizumab for oligomEtastatic cOlorectal Cancer With unResectable lIver MeTastasEs (METEORITE)","sponsor":"Brown University","participation":[{"nct":"NCT06555133","source":"https://clinicaltrials.gov/study/NCT06555133","fetchedAt":"2026-10-07T16:54:48.431Z","studySha256":"8b93645b995da9b0d43a6cc27264581053e01b0b2e04093078894fcab76d8ad7","overallStatus":"RECRUITING","lastUpdatePosted":"2026-08-20","leadSponsor":"Brown University","collaboratorCount":2,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":18,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["United States"]}],"started":"2025-04-07","startedType":"actual","enrolled":18,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06555133/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"company":[{"id":"sirtex","kind":"company","name":"Sirtex Medical","route":"/companies/sirtex/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}